213 related articles for article (PubMed ID: 36369903)
1. Shikonin reverses pyruvate kinase isoform M2-mediated propranolol resistance in infantile hemangioma through reactive oxygen species-induced autophagic dysfunction.
Yang E; Wang X; Huang S; Li M; Li Y; Geng Y; Liu X; Chen Z; Zhang D; Wu H
Cancer Sci; 2023 Mar; 114(3):806-821. PubMed ID: 36369903
[TBL] [Abstract][Full Text] [Related]
2. Propranolol for treatment of ulcerated infantile hemangiomas.
Saint-Jean M; Léauté-Labrèze C; Mazereeuw-Hautier J; Bodak N; Hamel-Teillac D; Kupfer-Bessaguet I; Lacour JP; Naouri M; Vabres P; Hadj-Rabia S; Nguyen JM; Stalder JF; Barbarot S;
J Am Acad Dermatol; 2011 May; 64(5):827-32. PubMed ID: 21353332
[TBL] [Abstract][Full Text] [Related]
3. Infantile hemangiomas: what have we learned from propranolol?
Hagen R; Ghareeb E; Jalali O; Zinn Z
Curr Opin Pediatr; 2018 Aug; 30(4):499-504. PubMed ID: 29846253
[TBL] [Abstract][Full Text] [Related]
4. Initial experiences with propranolol treatment of infantile hemangiomas: report of three cases.
Halilbasic A; Hotic N; Husaric E; Rahmanovic E; Halilbasic M; Husaric S
Med Arh; 2011; 65(6):380-2. PubMed ID: 22299307
[TBL] [Abstract][Full Text] [Related]
5. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
[TBL] [Abstract][Full Text] [Related]
6. Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas.
Kim LHC; Hogeling M; Wargon O; Jiwane A; Adams S
J Pediatr Surg; 2011 Apr; 46(4):759-763. PubMed ID: 21496551
[TBL] [Abstract][Full Text] [Related]
7. [Chinese experts consensus on the use of oral propranolol for treatment of infantile hemangiomas].
Zheng JW; Wang XK; Qin ZP; Fan XD; Li K; Yang YW; Huo R; Liu SH; Zhao JH; Wang XY; Zhou DK
Shanghai Kou Qiang Yi Xue; 2016 Jun; 25(3):257-60. PubMed ID: 27609372
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and management of infantile hemangiomas.
Püttgen KB
Pediatr Clin North Am; 2014 Apr; 61(2):383-402. PubMed ID: 24636652
[TBL] [Abstract][Full Text] [Related]
9. Successful management of airway hemangioma with propranolol.
Mendiratta V; Varghese B; Chander R; Parakh A; Solanki RS
Int J Dermatol; 2013 Jun; 52(6):750-2. PubMed ID: 23679882
[TBL] [Abstract][Full Text] [Related]
10. Is Infantile Hemangioma a Neuroendocrine Tumor?
Kaulanjan-Checkmodine P; Oucherif S; Prey S; Gontier E; Lacomme S; Loot M; Miljkovic-Licina M; Cario M; Léauté-Labrèze C; Taieb A; Moisan F; Rezvani HR
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563552
[TBL] [Abstract][Full Text] [Related]
11. β-blocker therapy for infantile hemangioma.
Koh SP; Leadbitter P; Smithers F; Tan ST
Expert Rev Clin Pharmacol; 2020 Aug; 13(8):899-915. PubMed ID: 32662682
[TBL] [Abstract][Full Text] [Related]
12. Enhanced efficacy of propranolol therapy for infantile hemangiomas based on a mesoporous silica nanoplatform through mediating autophagy dysfunction.
Wu H; Wang X; Liang H; Zheng J; Huang S; Zhang D
Acta Biomater; 2020 Apr; 107():272-285. PubMed ID: 32145394
[TBL] [Abstract][Full Text] [Related]
13. Multiple cutaneous and hepatic infantile hemangiomas having a successful response to propranolol as monotherapy at neonatal period.
Cavalli R; Novotna V; Buffon RB; Gelmetti C
G Ital Dermatol Venereol; 2013 Oct; 148(5):525-30. PubMed ID: 24005146
[TBL] [Abstract][Full Text] [Related]
14. [The advance of β-blockers in the treatment of infantile hemangiomas].
Lin TT; He YJ
Zhonghua Yan Ke Za Zhi; 2013 Dec; 49(12):1138-44. PubMed ID: 24499701
[TBL] [Abstract][Full Text] [Related]
15. [Propranolol in infantile hemangiomas].
Léauté-Labrèze C
Arch Pediatr; 2015 Apr; 22(4):452-5. PubMed ID: 25753275
[TBL] [Abstract][Full Text] [Related]
16. A further experience of propranolol for severe infantile hemangiomas of the face: an observational study.
Greco A; D'Erme AM; Zamma Gallarati B; Caputo R; de Martino M
Dermatol Ther; 2014; 27(4):198-202. PubMed ID: 24548454
[TBL] [Abstract][Full Text] [Related]
17. Role of Thrombospondin-1 and Nuclear Factor-κB Signaling Pathways in Antiangiogenesis of Infantile Hemangioma.
Xu W; Li S; Yu F; Zhang Y; Yang X; An W; Wang W; Sun C
Plast Reconstr Surg; 2018 Sep; 142(3):310e-321e. PubMed ID: 30148773
[TBL] [Abstract][Full Text] [Related]
18. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
J Cutan Med Surg; 2012; 16(2):115-21. PubMed ID: 22513064
[TBL] [Abstract][Full Text] [Related]
19. [Infantile hemangioma and propranolol: a therapeutic "revolution". Literature review].
Yilmaz L; Dangoisse C; Semaille P
Rev Med Brux; 2013; 34(6):479-84. PubMed ID: 24505868
[TBL] [Abstract][Full Text] [Related]
20. Retrospective case series of increased oral propranolol dosage for infantile hemangiomas.
Huang AH; Mannschreck D; Aggarwal P; Mahon M; Cohen BA
Pediatr Dermatol; 2020 Nov; 37(6):1057-1062. PubMed ID: 32869385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]